FDA Drugs (New Approvals & NDA)Original article
Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
RegulatoryCyclophosphamide for Injection, USPNegative
AI Analysis
Summary
Sunny Pharmtech initiated a voluntary nationwide recall of three lots of Cyclophosphamide for Injection, USP due to the presence of steel particulate matter. No adverse events or injuries have been reported to date.
Outcome Details
Voluntary nationwide recall due to presence of particulate matter (steel) in three lots of cyclophosphamide for injection (1g/vial and 2g/vial)
Importance:6/10
Sentiment:
-0.70
product recallmanufacturing qualityparticulate contaminationsafety
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 17, 2026 2:09 PM